PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Lauds Toscana Biomarkers' Outstanding Contributions to the R&D of Novel Biomarkers for the Diagnosis of Autoimmune Diseases - Based on its recent analysis of the autoimmune disease diagnostics markets, Frost & Sullivan recognizes Toscana Biomarkers with the 2008 European Frost & Sullivan Excellence in Research Award
Frost & Sullivan Lauds Toscana Biomarkers' Outstanding Contributions to the R&D of Novel Biomarkers for the Diagnosis of Autoimmune Diseases

 

NewswireToday - /newswire/ - London, United Kingdom, 2009/01/13 - Based on its recent analysis of the autoimmune disease diagnostics markets, Frost & Sullivan recognizes Toscana Biomarkers with the 2008 European Frost & Sullivan Excellence in Research Award.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The company demonstrated that the incorporation of synthetically modified peptides for the validation and discovery of biomarkers aids effective diagnosis of autoimmune diseases and is also looking to adopt robust methods to identify novel diagnostic solutions.

Biomarkers have been used extensively in the genetic and molecular analysis of complications such as autoimmune diseases. Toscana Biomarkers focuses on identifying specific biomarkers detectable in patients' serum samples and validating the same with respect to the disease progression and activity.

"Antigenic peptides that can selectively and specifically recognise autoantibodies can be used in immunoenzymatic assays to detect disease biomarkers," says Frost & Sullivan Research Analyst Suraj Ramanathan. "Therefore, the company aims to develop robust biomarkers panel for the diagnosis of autoimmune diseases ranging from rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) to more complex diseases such as multiple sclerosis (MS) and systemic sclerosis."

To complement its focus on the manufacture of novel disease biomarkers, Toscana Biomarkers is working on developing in-vitro diagnostic assays, especially the enzyme-linked immuno sorbent assay (ELISA) for autoimmune diseases.

The company's R&D revolves around a peptide-based reverse approach [chemical reverse approach (CRA)], which indicates that the screening of antigenic probes is primarily guided by the antibodies circulating in a patient's biological fluids. The circulating auto-antibodies help recognise and optimise the molecular ('chemical') structure of defined and pre-disposed peptide libraries.

"The synthetic post-translationally modified peptides get well recognized by the auto-antibodies, effectively mimicking the neo-antigenic epitopes," notes Suraj Ramanathan. "These peptides could be further screened and used as antigenic probes for the detection of potential biomarkers for each specific disease."

To make optimum use of the potential post-translational modifications (PTMs) associated with the pathogenesis of autoimmune diseases, Toscana Biomarkers aims at providing novel diagnostic solutions using disease biomarkers. PTMs such as lipidation, citrullination, and glycosylation play a vital role in antigen recognition, as they are known to alter its immunogenicity and function. Such modifications change the antigens' structural integrity, making them 'neo-antigens' and triggering an immune response (autoimmune).

"Researchers are in the process of introducing synthetically developed antigens subjected to chemical modifications," observes Suraj Ramanathan. "Such synthetic peptides univocally charaterised mimic the native neo-antigens."

Each year, Frost & Sullivan presents this award to the company that has carried out new 'disruptive' research; and has, in general, a strong commitment to R&D. This award recognizes a company's R&D program that has or is expected to bring significant contributions to the industry in terms of adoption, change, and competitive posture. The award also recognizes the company's overall research excellence as well as its commitment toward differentiating itself based on science-backed services or solutions.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Toscana Biomarkers
Toscana Biomarkers S.r.l. (toscanabiomarkers.com), headquartered in Siena, Italy, develops innovative diagnostic test kits for the detection and identification of specific biomarkers related to autoimmune diseases. Using a variety of methods based on its proprietary technology, these tests are aimed to provide accuracy, simplicity, and speed in the early diagnosis and treatment of chronic medical conditions such as rheumatoid arthritis and multiple sclerosis. These products are also intended to enhance patient well-being and to reduce associated healthcare costs.

Toscana Biomarkers Contact:
Anna Maria Papini, Chief Scientific Officer
Toscana Biomarkers Srl,
T: +39 0577 1916272
E: papini[.]toscanabiomarkers.com.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting, and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Lauds Toscana Biomarkers' Outstanding Contributions to the R&D of Novel Biomarkers for the Diagnosis of Autoimmune Diseases

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Ciara Jamie Connolly 
+44 (0) 207.915.7868 ciara.connolly[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)